Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema

Fig. 2

Representative figures at each time point of two cases of Ozurdex-treated central retinal vein occlusion (CRVO) eyes with cilioretinal artery occlusion. A patient between the ages of 25 and 29 years (a) and a patient between the ages of 35 and 39 years (b) with CRVO and cilioretinal artery occlusion in their left and right eye each. Disc swelling and cilioretinal artery occlusion were significantly improved at 1 month after injection (a). Severe tortuosity and congestion of central retinal veins decreased gradually, and were nearly resolved at 1 year follow-up (a). Dramatic Improvements in disc swelling, vascular changes, and severe retinal hemorrhages were noted only 1 week later the treatment, and the favorable condition remained well until 1 year (b)

Back to article page